Synthesis and evaluation of adenosine derivatives as A1, A2A, A2B and A3 adenosine receptor ligands containing boron clusters as phenyl isosteres and selective A3 agonists

European Journal of Medicinal Chemistry
2021.0

Abstract

A series of adenosine and 2'-deoxyadenosine pairs modified with a 1,12-dicarba-closo-dodecaborane cluster or alternatively with a phenyl group at the same position was synthesized, and their affinity was determined at A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub> and A<sub>3</sub> adenosine receptors (ARs). While AR affinity differences were noted, a general tendency to preferentially bind A<sub>3</sub> AR over other ARs was observed for most tested ligands. In particular, 5'-ethylcarbamoyl-N<sup>6</sup>-(3-phenylpropyl)adenosine (18), N<sup>6</sup>-(3-phenylpropyl)-2-chloroadenosine (24) and N<sup>6</sup>-(3-phenylpropyl)adenosine (40) showed nanomolar A<sub>3</sub> affinity (K<sub>i</sub> 4.5, 6.4 and 7.5 nM, respectively). Among the boron cluster-containing compounds, the highest A<sub>3</sub> affinity (K<sub>i</sub> 206 nM) was for adenosine derivative 41 modified at C2. In the matched molecular pairs, analogs bearing boron clusters were found to show lower binding affinity for adenosine receptors than the corresponding phenyl analogs. Nevertheless, interestingly, several boron cluster modified adenosine ligands showed significantly higher A<sub>3</sub> receptor selectivity than the corresponding phenyl analogs: 7vs. 8, 15vs. 16, 17vs. 18.

Knowledge Graph

Similar Paper

Synthesis and evaluation of adenosine derivatives as A1, A2A, A2B and A3 adenosine receptor ligands containing boron clusters as phenyl isosteres and selective A3 agonists
European Journal of Medicinal Chemistry 2021.0
Search for New Purine- and Ribose-Modified Adenosine Analogs as Selective Agonists and Antagonists at Adenosine Receptors
Journal of Medicinal Chemistry 1995.0
5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives:  Partial Agonists for the Adenosine A<sub>1</sub> and A<sub>3</sub> Receptors
Journal of Medicinal Chemistry 2001.0
2-Substitution of N6-Benzyladenosine-5'-uronamides Enhances Selectivity for A3 Adenosine Receptors
Journal of Medicinal Chemistry 1994.0
Synthesis and Biological Activity of New Potential Agonists for the Human Adenosine A<sub>2A</sub> Receptor
Journal of Medicinal Chemistry 2004.0
N9-Benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: Synthesis and structure–activity relationships at adenosine A1 and A2A receptors
Bioorganic &amp; Medicinal Chemistry 2007.0
Structural Determinants of A<sub>3</sub> Adenosine Receptor Activation:  Nucleoside Ligands at the Agonist/Antagonist Boundary
Journal of Medicinal Chemistry 2002.0
N<sup>6</sup>,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A<sub>3</sub> Receptor
Journal of Medicinal Chemistry 1999.0
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity
Journal of Medicinal Chemistry 2016.0
Methanocarba Analogues of Purine Nucleosides as Potent and Selective Adenosine Receptor Agonists
Journal of Medicinal Chemistry 2000.0